These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 4864593)

  • 21. The effect of hypothalamic lesions on the melanocyte stimulating hormone content and histology of the pars intermedia of the rat pituitary gland.
    Howe A; Thody AJ
    J Physiol; 1969 Mar; 201(1):25P-26P. PubMed ID: 5773561
    [No Abstract]   [Full Text] [Related]  

  • 22. Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro.
    Krulich L; Dhariwal AP; McCann SM
    Endocrinology; 1968 Oct; 83(4):783-90. PubMed ID: 4879544
    [No Abstract]   [Full Text] [Related]  

  • 23. Release of pituitary melanocyte-stimulating hormone by the oxytocin fragment, H-Cys-Tyr-Ile-Gln-Asn-Oh.
    Celis ME; Taleisnik S; Walter R
    Biochem Biophys Res Commun; 1971 Nov; 45(3):564-9. PubMed ID: 4942720
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of median eminence lesions on the function of multiple pituitary homografts with particular reference to the secretion of gonadotrophins and growth hormone.
    Beddow DG; McCann SM
    Endocrinology; 1969 Mar; 84(3):595-605. PubMed ID: 4886349
    [No Abstract]   [Full Text] [Related]  

  • 25. IN VITRO AND IN VIVO STIMULATION OF THE RELEASE OF LUTEINIZING HORMONE.
    SCHALLY AV; BOWERS CY
    Endocrinology; 1964 Sep; 75():312-20. PubMed ID: 14235397
    [No Abstract]   [Full Text] [Related]  

  • 26. Storage of prolactin-inhibiting factor in the hypothalamus of perphenazine-treated rats.
    Danon A; Sulman FG
    Neuroendocrinology; 1970; 6(5):295-300. PubMed ID: 4921378
    [No Abstract]   [Full Text] [Related]  

  • 27. Cellular control of melanocyte stimulating hormone secretion.
    Hadley ME; Davis MD; Morgan CM
    Front Horm Res; 1977; 4():94-104. PubMed ID: 26618
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro formation of a MSH-releasing agent by hypothalamic extracts.
    Celis ME; Taleisnik S
    Experientia; 1971 Dec; 27(12):1481-2. PubMed ID: 5144873
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of hypothalamic lesions on immuno-reactive alpha-melanocyte stimulating hormone secretion in the rat.
    Penny RJ; Tilders FJ; Thody AJ
    J Physiol; 1979 Jul; 292():59-67. PubMed ID: 490393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma and pituitary MSH levels in the rat after lesions of the hypothalamus.
    Thody AJ
    Neuroendocrinology; 1974; 16(5-6):323-31. PubMed ID: 4449591
    [No Abstract]   [Full Text] [Related]  

  • 31. Effect of amygdaloid nuclear lesions on hypothalamic luteinizing hormone-releasing factor in the male deermouse.
    Eleftheriou BE
    J Endocrinol; 1967 Aug; 38(4):479-80. PubMed ID: 5339867
    [No Abstract]   [Full Text] [Related]  

  • 32. MSH activity in plasma and pituitaries of rats after various treatments.
    Kastin AJ; Schally AV; Viosca S; Miller MC
    Endocrinology; 1969 Jan; 84(1):20-7. PubMed ID: 4881999
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of background adaptation, length of exposure time and hypophysectomy on the quantity of melanophore stimulating substances in the hypothalamo hypophyseal complex of Rana pipiens.
    Preslock JP; Bercu BB; Brinkley HJ
    Gen Comp Endocrinol; 1972 Oct; 19(2):313-9. PubMed ID: 4539045
    [No Abstract]   [Full Text] [Related]  

  • 34. Maintenance of growth hormone releasing activity in the hypothalamus of long-term hypophysectomized rats.
    Falconi G; Müller E; Pecile A
    Experientia; 1966 May; 22(5):333. PubMed ID: 5957229
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of reserpine on the pituitary content of melanocyte-stimulating hormone and on hypothalamic factors which affect its release.
    Tomatis ME; Taleisnik S
    J Endocrinol; 1968 Dec; 42(4):505-12. PubMed ID: 4886788
    [No Abstract]   [Full Text] [Related]  

  • 36. Pituitary GH and hypothalamic GHRF after median eminence implantation of ovine or human GH.
    Voogt JL; Clemens JA; Negro-Vilar A; Welsch C; Meites J
    Endocrinology; 1971 Jun; 88(6):1363-7. PubMed ID: 4929558
    [No Abstract]   [Full Text] [Related]  

  • 37. MSH activity in pituitary glands of rats treated with tranquilizing drugs.
    Kastin AJ; Schally AV
    Endocrinology; 1966 Nov; 79(5):1018-20. PubMed ID: 5951274
    [No Abstract]   [Full Text] [Related]  

  • 38. Thyrotrophic hormone secretion in rats after partial or total interruption of nueral afferents to the medial basal hypothalamus.
    Halász B; Florsheim WH; Corcorran NL; Gorski RA
    Endocrinology; 1967 Jun; 80(6):1075-82. PubMed ID: 4165266
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the release of follicle-stimulating hormone in vitro from rat pituitary glands stimulated by hypothalamic follicle-stimulating hormone-releasing factor.
    Jutisz M; De la Llosa MP
    Endocrinology; 1967 Dec; 81(6):1193-202. PubMed ID: 4863718
    [No Abstract]   [Full Text] [Related]  

  • 40. The hypothalamo-hypophyseal rat explant in vitro: endocrinological studies of the pars intermedia dopaminergic neural input.
    Davis MD
    J Physiol; 1986 Jan; 370():381-93. PubMed ID: 3958980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.